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Abstract
Background: Genetic instability is a hallmark of tumours and preneoplastic lesions. The predominant
form of genome instability in human cancer is chromosome instability (CIN). CIN is characterized by
chromosomal aberrations, gains or losses of whole chromosomes (aneuploidy), and it is often associated
with centrosome amplification. Centrosomes control cell division by forming a bipolar mitotic spindle and
play an essential role in the maintenance of chromosomal stability.
However, whether centrosome amplification could directly cause aneuploidy is not fully established. Also,
alterations in genes required for mitotic progression could be involved in CIN.
A major candidate is represented by Aurora-A/STK15 that associates with centrosomes and is
overexpressed in several types of human tumour.
Methods:  Centrosome amplification were induced by hydroxyurea treatment and visualized by
immunofluorescence microscopy. Aurora-A/STK15 ectopic expression was achieved by retroviral
infection and puromycin selection in HCT116 tumour cells. Effects of Aurora-A/STK15 depletion on
centrosome status and ploidy were determined by Aurora-A/STK15 transcriptional silencing by RNA
interference. Changes in the expression levels of some mitotic genes were determined by Real time RT-
PCR.
Results: We investigated whether amplification of centrosomes and overexpression of Aurora-A/STK15
induce CIN using as a model system a colon carcinoma cell line (HCT116). We found that in HCT116
cells, chromosomally stable and near diploid cells harbouring a MIN phenotype, centrosome amplification
induced by hydroxyurea treatment is neither maintained nor induces aneuploidy. On the contrary, ectopic
overexpression of Aurora-A/STK15 induced supernumerary centrosomes and aneuploidy. Aurora-A/
STK15 transcriptional silencing by RNA interference in cells ectopically overexpressing this kinase
promptly decreased cell numbers with supernumerary centrosomes and aneuploidy.
Conclusion:  Our results show that centrosome amplification alone is not sufficient to induce
chromosomal instability in colon cancer cells with a MIN phenotype. Alternatively, centrosome
amplification has to be associated with alterations in genes regulating mitosis progression such as Aurora-
A/STK15 to trigger CIN.
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Background
Genome instability is a hallmark of the vast majority of
human cancers. Nearly 100 years ago, Boveri T.(1914),
found that cells containing more than 2 centrosomes seg-
regate their chromosomes abnormally because of the
presence of extra spindle poles. Genetic instability is
expressed in cancers by an increased rate of a number of
different genetic alterations. These different manifesta-
tions of genetic instability are classified into two major
categories. The first one involves subtle changes in DNA
sequences typically represented by microsatellite instabil-
ity (MIN). The second one is characterized by gains and
losses of whole or parts of chromosomes, named chromo-
somal instability (CIN), and it is considered a driving
force for tumourigenesis [1]. MIN occurs in approxi-
mately 15% of colon cancers and results from inactivation
of the mismatch repair (MMR) system by either MMR
gene mutations or hypermethylation of the MLH1 pro-
moter [2]. The mechanisms inducing CIN in cancer and
more specifically in colon cancer are only partly under-
stood. At least two possible causes, not mutually exclu-
sive, could be responsible for CIN: mutations in genes
encoding mitotic regulators, such as spindle checkpoint
proteins, and defects in genes controlling centrosome
homeostasis. The presence of mutations of the mitotic
checkpoint regulators BUB1 and BUBR1 and amplifica-
tion of Aurora-A/STK15 (also known as BTAK, Aurora 2,
and AIK1) in a subset of human colon cancers have sug-
gested that CIN results primarily from deregulation of
DNA replication and mitotic-spindle checkpoints [3].
Aurora-A/STK15 is a member of the Aurora/Ipl1p family
of mitotic regulated serine/threonine kinases that are key
regulators of chromosome segregation and cytokinesis
[4]. The Aurora-A/STK15 gene maps to chromosome
20q13.2, a region commonly found amplified in several
epithelial cancers [5]. Overexpression of the Aurora-A/
STK15 gene is often associated with centrosome amplifi-
cation, chromosomal instability, aneuploidy, and trans-
formation. Aurora-A/STK15 overexpression has been
detected in a variety of human cancers and cell lines
including breast, ovarian, colon, prostate, and neuroblas-
toma cancer cell lines [6]. Aurora-A/STK15 is also known
to play a role in centrosome maturation and migration
that are key events to organize a functional mitotic spin-
dle. Centrosomes are crucially involved in the mainte-
nance of genomic stability by organizing a bipolar mitotic
spindle ensuring equal segregation of replicated chromo-
somes to daughter cells [7]. Consequently, defects involv-
ing centrosome changes in number, organization, and
behaviour, have been found in a variety of solid tumours
[8]. By increasing the incidence of multipolar spindles
and related spindle abnormalities, these defects can cause
chromosome mis-segregation and aneuploidy [9]. The
loss of genomic stability appears to be a key molecular
and pathogenetic step occurring early in tumourigenesis
creating a permissive environment for the occurrence of
alterations in tumour suppressor genes and oncogenes
[3]. Another protein involved in these processes is the
tumour suppressors p53, important regulator of the cell
cycle and apoptosis that is frequently inactivated in
human cancers. Furthermore, deletion of the p53 gene
results in centrosome amplification [10] that is reminis-
cent of one of the phenotypes induced by elevated expres-
sion of Aurora-A/STK15, suggesting a crosstalk between
the two proteins. Indeed it has been shown that Aurora-A/
STK15 phosphorylates p53 at serine 315 leading to its
ubiquitination by Mdm2 and degradation [11]. In co-
transfection experiments, p53 suppressed Aurora-A/
STK15 induced centrosome amplification and cellular
transformation in a transactivation-independent manner.
Moreover, it was observed that Aurora-A/STK15 abrogated
p53 DNA binding and transactivation activity by phos-
phorylation of serine 215 [12]. The suppression of
Aurora-A/STK15 oncogenic activity by p53 is explained in
part by the finding that p53 inhibited Aurora-A/STK15
kinase activity via direct interaction with the latter's
Aurora box [13]. Here we show that hydroxyurea induces
centrosome amplification in parental HCT116 cells as
well as in their isogenic derivatives with both the p53 and
the p21waf1  gene disrupted. However, the presence of
supernumerary centrosomes alone was not sufficient to
induce aneuploidy in these cells. In some cases extra cen-
trosomes, generally originating multipolar spindles, coa-
lesced forming a pseudo bipolar spindle. We observed
that after the release from the hydroxyurea block tumour
cells lose supernumerary centrosomes. On the contrary,
ectopic expression of Aurora-A/STK15 caused supernu-
merary centrosomes that were maintained over time and
likely generated subsequent aneuploidy. These alterations
seem to correlate with Aurora-A/STK15 overexpression. In
fact Aurora-A/STK15 transcriptional silencing by RNAi
decreases both cells with supernumerary centrosomes and
aneuploidy in HCT116 cells ectopically expressing
Aurora-A/STK15.
Results
Hydroxyurea induces extensive but transient centrosome 
amplification
Unlike the majority of solid tumours the mismatch repair-
defective (MIN) colon cancer cells have a normal chromo-
somal number and do not acquire chromosomal instabil-
ity (CIN) during the course of many divisions. Indeed
MIN and CIN phenotypes are considered mutually exclu-
sive [1]. We have tested if aneuploidy, caused by the pres-
ence of extra centrosomes, occurs in tumour cells with a
near-diploid karyotype (MIN). As a model system we used
the HCT116 chromosomally stable colorectal carcinoma
cell line (HCT-wt) and its isogenic derivatives p53-/- and
p21-/- (HCTp53KO, HCTp21KO), which have both p53
and p21waf1 alleles disrupted [14]. To this aim cells wereBMC Cancer 2007, 7:212 http://www.biomedcentral.com/1471-2407/7/212
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treated with hydroxyurea (HU), an inhibitor of ribonucle-
otide reductase activity that accumulated cells at the G1/S
border inducing centrosome amplification as previously
shown in rodent and human cells [15,16]. Flow citometry
analyses showed that cells HU treated for 48 hours
arrested in G1/S (figure 1). However, such arrest was tran-
sient and when cells were released in drug free medium
for 24 hours they entered the cell cycle even though with
different kinetics. We observed that a large number of
released cells accumulated in the G2/M phase of the cell
cycle and the percentage of cells in G2/M was greater for
the HCTp53KO cells. Parental HCT116 cells and their
derivatives were treated with HU to induce centrosome
amplification and any cell with more than two centro-
somes was scored as aberrant. Centrosome numbers were
estimated in cells growing onto coverslips by detecting the
centrosome associated protein γ-tubulin. Immunocyto-
chemistry and fluorescence microscopy revealed that
untreated cells did not show more than 1 or 2 centro-
somes, with the exception of the HCTp53KO cells which
showed 7% of cells with more than 2 centrosomes. HU
treatment increased the number of cells with supernumer-
ary centrosomes. Respectively, 8% and 6% of HCT-wt and
HCTp21KO cells showed amplified centrosomes. The
increase in centrosome numbers (figure 2A–B) has been
more evident in HCTp53KO cells (35%), suggesting that
lack of p53 allows extensive centrosome amplification.
The finding that p21KO cells did not show a large increase
Cell cycle distribution after HU treatment in HCT116 tumour cells Figure 1
Cell cycle distribution after HU treatment in HCT116 tumour cells. Cells were fixed and stained with anti-BrdU-
FITC antibody and PI, and analyzed by flow cytometry. In the corners of each panel are reported the percentages of cells in 
that phase. Representative dot plots of HCT116 tumour cells untreated, treated with HU for 48 hours and released for 24 
hours showing a similar profile despite of the genetic background.BMC Cancer 2007, 7:212 http://www.biomedcentral.com/1471-2407/7/212
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in centrosome number as shown by p53KO cells suggests
that disruption of the pathway that normally respond to
DNA damage, of which p21waf1 is an important compo-
nent, presumably is not involved in centrosomes amplifi-
cation caused by HU treatment. In order to establish
whether cells with multiple centrosomes could proliferate
maintaining these extra centrosomes, we performed
immunocytochemistry experiments at various times (one,
two and 10 days) after HU treatment. Surprisingly, the
number of cells harbouring supernumerary centrosomes
decreased as soon as 24 hours of release in drug free
medium. By two days after drug removal the numbers of
wild type and p21KO HCT116 cells with supernumerary
centrosomes were equals to those of untreated cells. On
the contrary, at the same time still 20–25% of HCTp53KO
showed supernumerary centrosomes. However, after ten
days from drug removal also in these cells the percentage
of cells with supernumerary centrosomes returned back to
the one of untreated cells (figure 2-B). At the end of HU
treatment (48 h) we scored the presence of mitotic cells
(3%) in p53KO cells. The majority of these mitotic cells
(60%) showed coalesced extra centrosomes that presum-
ably will arrange a pseudo bipolar mitotic spindle, while
the remaining mitotic cells showed extra centrosomes that
likely will arrange multipolar spindles (figure 2-C).
Ectopic overexpression of Aurora-A/STK15 triggers 
supernumerary centrosomes and aneuploidy
The results described above suggest that cells in which p53
is not functional and that show a basal level of centro-
some amplification could have altered expression of genes
necessary for centrosome homeostasis. To investigate this
issue further a Real time RT-PCR for Aurora-A/STK15,
MAD2 and BRCA1 was performed in both HCT-wt and
HCT-p53KO. Real time RT-PCR did not show any changes
in expression of MAD2L1 (a spindle checkpoint gene) and
BRCA1. On the contrary HCT-p53KO showed a two fold
increase of Aurora-A/STK15 expression (figure 3-A). To
assess whether Aurora-A/STK15 overexpression is able to
induce as well as maintain aneuploidy and extra centro-
somes we performed experiments in which this gene was
ectopically expressed in HCT-wt and in HCT-p53KO cells.
Cells were transfected with the pBPSTR1-Aurora-A/STK15
retroviral vector encoding for the full-length cDNA
Aurora-A/STK15 [17] and selected for two weeks in puro-
mycin. Selected cells, named HCT-STK15 and HCT-
p53KO-STK15, showed elevated levels of Aurora-A/STK15
protein by western blot (figure 3-B, upper panel) when
compared to control cells. As shown by Real time RT-PCR
increased protein levels of Aurora-A/STK15 in HCT-
p53KO-STK15 cells correlated with higher mRNA expres-
sion levels (figure 3-B, lower panel), where transcript
quantification is relative to that shown by untransfected
cells. Subsequently, we analyzed by immunofluorescence
microscopy both HCT-STK15 and HCT-p53KO-STK15
cells to determine if ectopic overexpression of Aurora-A/
STK15 was able to induce extra centrosomes (figure 3-C).
The presence of supernumerary centrosomes, as revealed
by γ-tubulin detection, was observed in 18% and 15% of
the cells respectively (figure 3-D). We also observed
mitotic spindle alterations in the majority of HCT-STK15
and HCT-p53KO-STK15 mitotic cells as revealed by β-
tubulin detection (figure 4-A). These multipolar spindles
underlie karyotipic alterations as revealed by conven-
tional cytogenetics performed at two weeks from the
infection, that showed the presence of aneuploidy in 97%
and 95% of HCT-STK15 and HCT p53KO-STK15 cells
respectively (figure 4B, left panel). In particular HCT-
STK15 cells showed high percentages of hypodyploid cells
(78%), while about 60% of HCT-p53KO-STK15 cells were
hyperdyploid (figure 4B). To ascertain whether the effects
described above were directly correlated with Aurora-A/
STK15 overexpression and not depending on additional
genetic changes that occurred during the selection, we
over-expressed Aurora-A/STK15 transiently. HCT-wt and
HCT-p53KO cells were co-transfected with the pBPSTR1-
STK15 vector and the H2B-GFP fusion expression vector
[18] to estimate transfection efficiency. After 72 hours
from transfection centrosome analysis by γ-tubulin detec-
tion revealed an increase of cells with multiple centro-
somes (figure 5-A) 37% in HCT-STK15 and 30% in HCT
p53KO-STK15 cells. In addition cytogenetics analysis
revealed high percentage of aneuploid cells in both HCT-
STK15 and HCTp53KO-STK15 where Aurora-A/STK15 is
overexpressed, confirming the results obtained in the sta-
bly selected cells (figure 5-B).
Time-lapse video microscopy of cells overexpressing 
Aurora-A/STK15
To detect the generation of aneuploid cells caused by
Aurora-A/STK15 overexpression we analyzed HCT-STK15
and p53KO-STK15 mitoses by time-lapse video micros-
copy. To visualize mitotic progression we followed H2B-
GFP-labeled chromosomes. The H2B-GFP fusion protein
decorates chromosomes and allows observation of live
cells that fluoresce green under the fluorescence micro-
scope [18]. We measured the duration of mitosis from
metaphase to chromosome decondensation in HCT-
STK15 and p53KO-STK15 cells compared to their normal
counterparts as a control to show that mitosis was not per-
turbed by the transfection procedure itself. We recorded
14 and 15 mitoses for HCT-STK15 and p53KO-STK15
cells on a total of 220 and 240 cells respectively. Of these
mitoses 60% and 85%respectively showed altered mitotic
progression. The completion of chromosome alignment
on the spindle equator (congression time) was set as T =
0, and the relative times of the onset of chromosome-to-
pole movement were determined. Because of possible
phototoxicity associated with fluorescence microscopy
the time interval between frames capture was limited toBMC Cancer 2007, 7:212 http://www.biomedcentral.com/1471-2407/7/212
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one frame every 3 min. HCT-wt and HCT-p53KO cells
(figure 5-C) underwent normal metaphase/anaphase
transition and completed mitosis in 30 minutes. Also
HCT-STK15 cells completed mitosis in 30 minutes,
although 8out of 14 of recorded mitosiss they showed
some unaligned/lagging chromosomes (arrow) that failed
to segregate properly. Such occurrence could originate
micronuclei in anaphase and result in the generation of
hypodiploid cells. We observed that 13 out of 15 of
recorded mitoses in HCT-p53KO-STK15 cells proceeded
into anaphase despite the presence of mal-oriented and
unaligned chromosomes and did not divide correctly. By
Centrosome amplification in HCT116 tumour cells after HU treatment Figure 2
Centrosome amplification in HCT116 tumour cells after HU treatment. (A) Centrosome abnormalities revealed by 
immunofluorescence microscopy detection of γ-tubulin (green) in HCT116 cells treated with HU, nuclei (blue) were stained 
with DAPI. The majority of HCT -wt and -p21KO cells showed normal centrosomes (arrows). Arrowheads indicate abnormal 
centrosomes in HCT-p53KO. (B) Histograms indicating percentages of centrosomes numbers in untreated, hydroxyurea 
treated (48 hours) and released (10 days) cells. (C) Presence of coalesced centrosomes (arrows, likely forming a pseudo-bipo-
lar spindle) and supernumerary centrosomes (arrowheads, likely forming a multipolar spindle) in HCT-p53KO cells.BMC Cancer 2007, 7:212 http://www.biomedcentral.com/1471-2407/7/212
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anaphase, cells contained errors in chromosome segrega-
tion that resulted in a delay (115 minutes) to complete
mitosis. Thus, we conclude that Aurora-A/STK15 ectopic
overexpression increases the rate of chromosome misseg-
regation and alters the time of the anaphase onset in HCT-
p53KO cells.
Aurora-A/STK15 silencing reduces supernumerary 
centrosomes, aneuploid cells and cause apoptosis in 
parental HCT116 cells
Next we aimed at confirming whether Aurora-A/STK15
overexpression in MIN cells generates chromosomal
instability likely via centrosome amplification. To this
aim we investigated if depletion of Aurora-A/STK15
expression by RNAi, in cells stably overexpressing Aurora/
STK15, was able to reduce supernumerary centrosomes
and aneuploidy cells compared to those observed in
parental cells. To this aim cells were transfected with spe-
Gene expression analysis in both HCT-wt and HCT-p53KO cells, presence of supernumerary centrosomes following Aurora- A/STK15 ectopic overexpression Figure 3
Gene expression analysis in both HCT-wt and HCT-p53KO cells, presence of supernumerary centrosomes fol-
lowing Aurora-A/STK15 ectopic overexpression. A) Real time RT-PCR relative quantification shows a two fold expres-
sion level of Aurora-A/STK15 gene in untreated HCT-p53KO cells. B) Western blot, upper panel, by anti-STK15 antibody 
shows increased protein levels of Aurora-A/STK15 in HCT-STK15 and p53KO-STK15 cells. Real time RT-PCR, lower histo-
gram, shows increased expression levels of Aurora-A/STK15 following infection of a retroviral vector encoding the full-length 
cDNA for Aurora-A/STK15. C) Centrosome analysis by γ-tubulin detection (green), nuclei stained with DAPI (blue). Arrow-
heads indicate abnormal centrosomes in HCT-STK15 and HCT-p53KO-STK15. D) Graphs summarize the percentage of cells 
with one, two or more than two centrosomes in untransfected or STK15 overexpressing cells.BMC Cancer 2007, 7:212 http://www.biomedcentral.com/1471-2407/7/212
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cific siRNAs against Aurora/STK15 messenger RNA. West-
ern blot analysis showed that RNA interference caused the
reduction of around 90% in the protein level of Aurora-A/
STK15 in both HCT-wt and HCTp53KO cells stably over-
expressing the kinase (figure 6-A). We also determined the
effects of RNA interference on cell cycle distribution. FAC-
Scan analyses showed a different effect likely related to the
p53 status of the cells. In fact cells with functional p53
arrested mainly in the G2/M phase of the cell cycle, and
some of them underwent apoptosis as revealed by the
presence of a subG1 peak of DNA content. In contrast we
have observed that p53 defective cells seem to enter the
cell cycle without appreciable apoptosis (figure 6-B). Then
we checked cells for changes in centrosome and chromo-
some numbers. By γ-tubulin detection we observed in p53
competent cells a reduction of the number of cells both
Alterations of the mitotic spindle and of ploidy following Aurora-A/STK15 overexpression in HCT-wt and HCT-p53KO cells Figure 4
Alterations of the mitotic spindle and of ploidy following Aurora-A/STK15 overexpression in HCT-wt and 
HCT-p53KO cells. A) Presence of multipolar spindles in HCT cells overexpressing Aurora-A/STK15 detected by β-tubulin 
(green) nuclei are stained with DAPI (blue): graphs summarize the percentages of normal and aberrant spindles in HCT-STK15 
and HCT-p53KO-STK15 cells. B) Examples of Giemsa stained aneuploid metaphases both hypodiploid and hyperdiploid; histo-
gram on the right shows percentages of both aneuploid and euploid metaphases in cells overexpressing Aurora-A/STK15.BMC Cancer 2007, 7:212 http://www.biomedcentral.com/1471-2407/7/212
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Centrosome and ploidy alterations after Aurora-A/STK15 transient overexpression and live cell imaging Figure 5
Centrosome and ploidy alterations after Aurora-A/STK15 transient overexpression and live cell imaging. A) 
Graph summarizes percentage of cells with one, two or more than two centrosomes in HCT cells overexpressing STK15 in 
transient. B) Percentages of aneuploid cells in HCT-STK15 and HCT-p53KO-STK15 C) Images of HCT-wt, HCT-STK15, HCT-
p53KO and HCT-p53KO-STK15 during mitosis by time-lapse microscopy. Cells expressed the H2B-GFP gene that decorates 
chromatin in green. Wild type and p53KO cells exit from mitosis in about 30 minutes. HCT-STK15 cells complete division also 
in 30 minutes but they show some metaphases with not aligned chromosomes (arrows) that might generate micronuclei. On 
the contrary HCT-p53KO-STK15 cells completed mitosis after 115 minutes undergoing an asymmetric division (arrowheads).BMC Cancer 2007, 7:212 http://www.biomedcentral.com/1471-2407/7/212
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with two and more than two centrosomes as well as an
increase of cells with only one centrosome (figure 6-C).
Conventional cytogenetics revealed in p53 competent
cells a substantial increase of near diploid cells after RNAi
(figure 6-D). On the contrary, we did not observe effects
of Aurora-A/STK15 transcriptional silencing in p53 defi-
cient cells. Such population showed a slight decrease of
cells with more than two centrosomes, but did not show
a decrease of the number of cells with chromosome alter-
ations. These last findings confirm a role for Aurora-A/
STK15 overexpression in the observed phenotype. Also
these results suggest that the differences observed in these
two cell types might be caused by the different p53 status
and might reflect the fact that once p53-/- cells acquire a
new chromosomal asset (aneuploid) these cells do not
need Aurora -A/STK15 overexpression to maintain it, so
that depletion of this kinase does not affect the number of
aneuploid cells
Discussion
Centrosome amplification and aneuploidy occur in
nearly all of solid tumours as well as in leukemia and lym-
Effects of silencing Aurora-A/STK15 by RNA interference in HCT-STK15 and HCT-p53KO-STK15 cells Figure 6
Effects of silencing Aurora-A/STK15 by RNA interference in HCT-STK15 and HCT-p53KO-STK15 cells. A) 
Western blot shows reduced expression of STK15 protein after 72 hours from siRNA transfection. B) FACScan analysis in 
HCT-STK15 and HCT-p53KO-STK15 cells left untreated and after 72 hours from siRNA transfection. DNA content was 
revealed by propidium iodide staining. HCT-STK15 cells show the presence of a sub-G1 peak indicating apoptosis in these 
cells. C) Histogram showing percentages of cells with the indicated centrosome numbers. D) Histogram showing percentages 
of aneuploid cells in both untransfected and silenced cells. Results in C and D were from three independent experiments (100–
200 cells each) and bars indicate standard errors from the mean.BMC Cancer 2007, 7:212 http://www.biomedcentral.com/1471-2407/7/212
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phoma and are considered early features of tumour initi-
ation and progression [19]. However, the presence of
multiple centrosome not always results in chromosomal
instability [20]. In the attempt to obtain additional evi-
dence on this phenomenon we treated HCT-wt cells har-
bouring a MIN phenotype and their isogenic derivatives
with hydroxyurea that alters the synchrony between DNA
and centrosome duplication. Our results show that
hydroxyurea induces centrosome amplification in HCT-
wt cells and in its derivatives. Such findings are consistent
with what previously reported both in rodent and human
cells [16,15]. However, in HCT-p21KO cells the frequency
of cells with supernumerary centrosomes was much lower
than that showed by their p53KO siblings and more sim-
ilar to that of HCT-wt cells. This last finding suggests that
disruption of the pathway normally responding to DNA
damage, of which p21waf1 is an important component,
likely is not involved in centrosome amplification medi-
ated by hydroxyurea treatment. Hydroxyurea treated cells
failed to maintain supernumerary centrosomes and none
of the cell lines analyzed became aneuploid despite the
initial presence of a large percentage of cells with ampli-
fied centrosomes. These results suggest that supernumer-
ary centrosomes can be induced in HCT-wt cells as well as
in their derivatives, but they are not maintained over time.
Lack of aneuploidy in these cells could be explained by
the fact that cells with multiple centrosomes are killed to
avoid chromosome instability driven by extra mitotic
poles formation. Alternatively, coalesced (clustered)
supernumerary centrosomes, may segregate chromo-
somes correctly likely forming a pseudo bipolar mitotic
spindle [8,21]. This could explain why chromosome
instability does not occur after release from the HU block,
despite of the transient deregulation of the centrosome
cycle induced by HU.
These findings suggest that other genes involved in
genomic stability and/or centrosome homeostasis should
be altered to create a permissive environment that allows
HCT116 cells to undergo and perpetuate both centrosome
amplification and aneuploidy. By Real-time RT-PCR we
looked at changes in expression of some of these genes in
HCT-p53KO cells that have a higher basal level of centro-
some amplification, and found Aurora-A/STK15 overex-
pression. Aurora-A/STK15 is localized to centrosomes
during interphase and it is essential for their maturation
as well as for mitotic progression. It has been also reported
that ectopic overexpression of Aurora-A/STK15 in
NIH3T3 and immortalized Rat-1 induces cells transfor-
mation that generates tumours when implanted in nude
mice [17,6]. However, overexpression of Aurora-A/STK15
in primary MEFs does not induce transformation [22] sug-
gesting that additional mutations/alterations are required.
We found that stable ectopic overexpression of Aurora-A/
STK15 in HCT-wt and HCT-p53KO cells caused aneu-
ploidy and centrosome alterations that were maintained
over time. Transient overexpression of Aurora-A/STK15
confirmed that these effects were directly correlated to the
presence of high levels of this kinase in these cells. The
same experiments ruled out that such effects depended on
additional genetic changes occurring during selection of
the cells. These results presented here are also consistent
with recent papers showing that Aurora-A/STK15 overex-
pression causes genetic instability and mammary tumour
formation in mice [23,24].
Depletion of Aurora-A/STK15 expression by RNAi in
HCT-wt cells stably overexpressing this kinase decreased
both aneuploidcells and cells with supernumerary centro-
somes confirming a role for Aurora-A/STK15 overexpres-
sion in the described phenotype. On the contrary, in HCT-
p53KO cells stably overexpressing Aurora-A/STK15 -/- the
reduction of the kinase levels by RNAi did not affect CIN
and reduced slightly cells with supernumerary centro-
somes. This last result suggests that once aneuploidy has
been induced Aurora-A/STK15 overexpression could be
no more necessary to sustain proliferation of aneuploid
cells.
These differences could be attributable to p53 which can
be affected by Aurora-A/STK15 phosphorylation at Ser215
causing in turn abrogation of p53 DNA binding and trans-
activation activity [12]. In normal cells with wt-p53 func-
tions Aurora-A/STK15 protein levels are controlled at least
in part by the Fbxw7 ubiquitin ligase [25]. Loss of p53
could lead to upregulation of Aurora-A/STK15 at protein
level mediated by downregulation of Fbxw7 expression.
Then, Aurora-A/STK15 ectopic upregulation and inactiva-
tion of p53 tumour suppressor pathway could cooperate
to drive initial centrosome amplification and aneuploidy
in HCT116 cells.
Finally, as recently showed by Sluder and Nordberg in
p53-/- MEFs [26] our results call attention to different con-
sequences caused by the presence of multiple centro-
somes in relationship to the genetic background of the
cell. In particular the results we obtained suggest that mul-
tiple centrosome could be a prerequisite to generate ane-
uploidy in cells that have Auorora-A/STK15
overexpression or that lack of important functions such as
those under pRB control [27,15]. On the other hand the
outcome of HU treatment in HCT116 cells suggest that to
avoid deleterious effects caused by extra poles tumour
cells could evolve specific means (i.e.coalescence) to deal
with the presence of multiple centrosomes.BMC Cancer 2007, 7:212 http://www.biomedcentral.com/1471-2407/7/212
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Conclusion
Here we show that the presence of only centrosome
amplification is not sufficient to trigger aneuploidy both
in HCT116 tumour cells and in their derivatives with the
p53 and p21 genes disrupted. The presence in some cases
of clustered extra centrosomes, so forming a pseudo bipo-
lar spindle, could in part explain this result. On the con-
trary, ectopic overexpression of Aurora-A/STK15 causes
centrosome amplification that is maintained over time
and in turn it results in aneuploidy. Both of these altera-
tions (centrosome amplification and aneuploidy) seem
directly correlated with Aurora-A/STK15 ectopic overex-
pression since its transcriptional silencing by RNA inter-
ference decreases both cells with supernumerary
centrosomes and reduced the frequency of aneuploid
cells. Finally, our findings suggest that centrosome ampli-
fication has to be associated to alterations in genes regu-
lating mitosis progression to trigger chromosomal
instability.
Methods
Cells and cell culture
The human colon cancer cell line HCT116 and its deriva-
tives HCTp21KO and HCTp53KO (a generous gift of Prof
B.Vogelstein) which have both p53 and p21 alleles dis-
rupted respectively [14], and HCT-STK15 (expressing
Aurora-A/STK15) were cultured in DMEM supplemented
with 10% FBS, 100 units/ml penicillin and 0.1 mg/ml
streptomycin (Euroclone Ltd UK). HCT116 cells stably
expressing Aurora-A/STK15 were obtained by retroviral
gene transduction of the pBPSTR1 vector where the
Aurora-A/STK15 full length cDNA, (a generous gift of Dr.
JR. Bischoff) [17] was cloned. For live cells imaging
HCT116 wt and p53KO cells were transfected with the
expression vector encoding the H2B histone fused in
frame with the Green Fluorescence Protein (H2B-GFP)
[18] using the Lipofectamine transfection reagent (Invit-
rogen). After 24 hours from transfection cells were
selected with 1 µg/mL of blasticidin and stable clones
were pooled.
Cell cycle analysis
Asynchronously growing cells were treated with 2 mM
hydroxyurea (Sigma) for 48 hours and then released into
complete medium without HU. Labelling with Bromode-
oxyUridine (BrdU) allowed monitoring of cells actively
engaged in DNA synthesis. DNA content was determined
using Propidium Iodide (PI) staining alone by treating the
cells with PBS containing 4 µg/ml of PI and 40 µg/ml
RNase. BrdU incorporation (10 µM for 4 hours) was used
to determine DNA synthesis of the released cells [28].
Analysis of BrdU labeled cells was conducted as described
previously and samples were analyzed on a Beckman
Coulter Epics-XL. Experiments were repeated at least
twice, 10000 events were analyzed by EXPO32 software
for each sample, and representative experiments are
shown.
Determination of ploidy
Asynchronous cells were treated with 0.2 µg/ml colcemid
(Demecolcine, Sigma) for 4 hours. Cells were harvested
by trypsinization, swollen in 75 mM KCl at 37°C, fixed
with 3:1 methanol/acetic acid (v/v), and dropped onto
clean, ice-cold glass microscope slides. The slides were air
dried and stained with 3% Giemsa in phosphate-buffered
saline for 10 min. Chromosome numbers were evaluated
using a Zeiss Axioskop microscope under a 100 × objec-
tive.
Immunofluorescence microscopy
To visualize multipolar spindles, cells were grown on
rounded glass coverslips and then fixed with 3.7% formal-
dehyde for 10 min at 37°C, permeabilized with 0.1% Tri-
ton X (Sigma) in PBS for 15 min and blocked with 0.1%
BSA for 30 min, both at room temperature. Coverslips
were incubated with a mouse monoclonal antibody
against β-tubulin (Sigma, diluted 1:200 in PBS) overnight
at 4°C, followed by a goat anti-mouse IgG-FITC conju-
gated secondary antibody (Sigma, diluted 1:100 in PBS)
for 1 hour at 37°C. For immunostaining of centrosomes
of asynchronously grown cells, we used a mouse mono-
clonal antibody against γ-tubulin (Sigma, diluted 1:4000
in PBS) incubated overnight at 4°C. Cells were washed in
PBS buffer and exposed to a FITC-conjugated goat anti-
mouse IgG secondary antibody (Sigma, diluted 1:100 in
PBS) for 1 hour at 37°C. Nuclei were visualized with 1 µg/
ml of 4',6-Diamidino-2-phenylindole (DAPI) and exam-
ined on a Zeiss Axioskop microscope equipped for fluo-
rescence, images were captured with a CCD digital camera
(AxioCam, Zeiss) and then transferred to Adobe Pho-
toShop for printing.
Western blotting
Protein concentration was measured using the Bio-Rad
Protein Assay (Bio-Rad Laboratories). Proteins (50 µg)
were separated by 10% SDS-PAGE containing 0.1% SDS
and transferred to Hybond-C nitrocellulose membranes
(Amersham Life Science) by electroblotting. The mem-
branes were sequentially incubated with goat anti-STK15
antibody (Santa Cruz) as primary antibody to visualize
Aurora A, and HRP-conjugated mouse anti goat IgG
(Santa Cruz) as a secondary antibody. The target protein
was detected with enhanced chemiluminescence Western
blotting detection reagents (PIERCE). Membranes were
stained by Ponceau Red to confirm equivalent loading of
total protein in all lanes.
RNA interference
Twenty-four hours after plating, cells were transfected
either with Aurora-A/STK15 siRNA at a final concentra-BMC Cancer 2007, 7:212 http://www.biomedcentral.com/1471-2407/7/212
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tion of 60 nM or with control siRNA. A 21-nucleotide
duplex siRNA for Aurora-A/STK15 with the following
sequence: 5'AUG CCC UGU CUU ACU GUC TT 3' was
synthesized by MWG. The day of transfection the siRNA
and the transfection reagent (Lipofectamine 2000, Invit-
rogen) were diluted separately in Opti-MEM (Invitrogen)
mixed gently and then incubated for 5 minutes at room
temperature. After incubation the siRNA and Lipo-
fectamine 2000 (Invitrogen) were mixed gently, allowed
to sit 30 minutes at room temperature to allow complex
formation, and added to the plates with 2 ml of D-MEM
for 72 hours.
Live cell time-lapse imaging
Cells were imaged in T25 flasks in CO2-independent
medium (GIBCO-BRL) at 37°C. Chromosome segrega-
tion was monitored on a heating plate (37°C) with an
inverted microscope and a 40x objective on a LEICA
inverted microscope equipped with a mercury 100 W
lamp. Under UV excitation, cells in metaphase were iden-
tified and mitotic progression was monitored every 3 min-
utes on average. Mitotic progression was documented
with a CCD digital camera (AxioCam Zeiss) and then
transferred to Adobe PhotoShop.
Real time RT-PCR
Some genes were selected for Real time RT-PCR experi-
ments. Primers were designed with Primer Express soft-
ware (Applied Biosystems) choosing amplicons of
approximately 70–100 bp. The selected sequences were
tested against public databases (NCBI) to confirm the
identity of the genes. Total RNA was reverse-transcribed in
a final volume of 50 µL using the High Capacity c-DNA
Archive kit (Applied Biosystems) for 10 minutes at 25°C
and 2 hours at 37°C. For each sample 2 µL of cDNA, cor-
responding to 100 ng of reverse transcribed RNA, were
analyzed by Real time RT-PCR (95°C for 15 sec, 60°C for
60 sec repeated for 40 cycles), in quadruplicate, using the
ABI PRISM 7300 instrument (Applied Biosystems). Real
time RT-PCR was done in a final volume of 20 µl compris-
ing 1x Master Mix SYBR Green (Applied Biosystems) and
0,3 µM of forward and reverse primers for: MAD2 (Fwd: 5'-
GCCGAGTTTTTCTCATTTGG-3'; Rev 5'-CCGATTCT-
TCCCACTTTTCA-3', Aurka (Fwd:5'-GTTCCC TTCG-
GTCCGAAAC-3'; Rev 5'-AATCATTTCCGGAGGCTG-3';
BRCA1 (Fwd:5'-CCTTGGCACAGGTGTCCAC-3'; Rev
5' GCCATTGTCCTCTGTCCAGG-3'; GAPDH (Fwd:5'-
CTCATGACCACAGTCCATGCC-3'; Rev 5'-GCCAATC-
CACAGTCTTCTGGGT-3'). Data were analyzed by averag-
ing quadruplicates Ct  (cycle threshold). Levels of RNA
expression were determined by using the SDS software ver-
sion (Applied Biosystems) according to the 2-∆∆ct method.
Levels of RNA expression of selected genes were normal-
ized to the internal control GAPDH.
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